196 related articles for article (PubMed ID: 2574722)
1. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transmitter release by botulinum neurotoxin A. Contribution of various fragments to the intoxication process.
Poulain B; Wadsworth JD; Maisey EA; Shone CC; Melling J; Tauc L; Dolly JO
Eur J Biochem; 1989 Oct; 185(1):197-203. PubMed ID: 2572418
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
[TBL] [Abstract][Full Text] [Related]
4. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
Poulain B; Tauc L; Maisey EA; Wadsworth JD; Mohan PM; Dolly JO
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4090-4. PubMed ID: 2897693
[TBL] [Abstract][Full Text] [Related]
5. A role for the interchain disulfide or its participating thiols in the internalization of botulinum neurotoxin A revealed by a toxin derivative that binds to ecto-acceptors and inhibits transmitter release intracellularly.
de Paiva A; Poulain B; Lawrence GW; Shone CC; Tauc L; Dolly JO
J Biol Chem; 1993 Oct; 268(28):20838-44. PubMed ID: 8104936
[TBL] [Abstract][Full Text] [Related]
6. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves.
Black JD; Dolly JO
J Cell Biol; 1986 Aug; 103(2):521-34. PubMed ID: 3733877
[TBL] [Abstract][Full Text] [Related]
7. Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in Aplysia.
Poulain B; Mochida S; Weller U; Högy B; Habermann E; Wadsworth JD; Shone CC; Dolly JO; Tauc L
J Biol Chem; 1991 May; 266(15):9580-5. PubMed ID: 1674511
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
Poulain B; Mochida S; Wadsworth JD; Weller U; Habermann E; Dolly JO; Tauc L
J Physiol (Paris); 1990; 84(4):247-61. PubMed ID: 1981913
[TBL] [Abstract][Full Text] [Related]
9. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.
Dolly JO; Ashton AC; McInnes C; Wadsworth JD; Poulain B; Tauc L; Shone CC; Melling J
J Physiol (Paris); 1990; 84(3):237-46. PubMed ID: 1963641
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
11. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
12. Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain.
Daniels-Holgate PU; Dolly JO
J Neurosci Res; 1996 May; 44(3):263-71. PubMed ID: 8723765
[TBL] [Abstract][Full Text] [Related]
13. Differences in the multiple step process of inhibition of neurotransmitter release induced by tetanus toxin and botulinum neurotoxins type A and B at Aplysia synapses.
Poulain B; De Paiva A; Deloye F; Doussau F; Tauc L; Weller U; Dolly JO
Neuroscience; 1996 Jan; 70(2):567-76. PubMed ID: 8848160
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between nerve-muscle transmission and nerve trophic effects on rat diaphragm using type D botulinum toxin.
Bray JJ; Harris AJ
J Physiol; 1975 Dec; 253(1):53-77. PubMed ID: 54420
[TBL] [Abstract][Full Text] [Related]
15. Cooperative action of the light chain of tetanus toxin and the heavy chain of botulinum toxin type A on the transmitter release of mammalian motor endplates.
Weller U; Dauzenroth ME; Gansel M; Dreyer F
Neurosci Lett; 1991 Jan; 122(1):132-4. PubMed ID: 1676142
[TBL] [Abstract][Full Text] [Related]
16. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization.
Dolly JO; Black J; Williams RS; Melling J
Nature; 1984 Feb 2-8; 307(5950):457-60. PubMed ID: 6694738
[TBL] [Abstract][Full Text] [Related]
17. Interactions between heavy metal chelators and botulinum neurotoxins at the mouse neuromuscular junction.
Sheridan RE; Deshpande SS
Toxicon; 1995 Apr; 33(4):539-49. PubMed ID: 7570639
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of the intracellular action of botulinum neurotoxin type A with monoclonal antibodies that map to light-chain epitopes.
Cenci Di Bello I; Poulain B; Shone CC; Tauc L; Dolly JO
Eur J Biochem; 1994 Jan; 219(1-2):161-9. PubMed ID: 7508383
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
